Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Biochemical and Biophysical Research Communications|April 6, 2018
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized miceYuji Teraoka, Takuro Uchida, Michio Imamura, et al.
World Journal of Gastroenterology|June 18, 2010
Fixation methods for electron microscopy of human and other liverEddie Wisse, Filip Braet, Hans Duimel, et al.
The Journal of Infectious Diseases|September 22, 2016
Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep SequencingHiromi Kan, Michio Imamura, Takuro Uchida, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized MiceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2023
Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorderKenzaburo Yamaji, Sadahiro Iwabuchi, Yuko Tokunaga, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 1, 2007
Single lymphocyte analysis with a microwell array chipYoshiharu Tokimitsu, Hiroyuki Kishi, Sachiko Kondo, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motifHiromi Yatsuji, Chiemi Noguchi, Nobuhiko Hiraga, et al.
Plos One|April 5, 2013
Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infectionShin-ichiro Nakagawa, Yuichi Hirata, Takeshi Kameyama, et al.
Plos One|March 3, 2017
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virusEisuke Miyaki, Nobuhiko Hiraga, Michio Imamura, et al.
Nature Biomedical Engineering|November 7, 2022
Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regionsKatsuya Sakai, Nozomi Sugano-Nakamura, Emiko Mihara, et al.
Pageof 15